Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients ...
Henry, D.,Vadhan-Raj, S.,Hirsh, V.,von Moos, R.,Hungria, V.,Costa, L.,Woll, P. J.,Scagliotti, G.,Smith, G.,Feng, A.,Jun, S.,Dansey, R.,Yeh, H.; Support Care Cancer. 2013 Oct 29.
See more >>
A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma.
Berenson, J.R., Matous, J., Swift, R.A., Mapes, R., Morrison, B., Yeh, H.S.; Clin Cancer Res. 2007 Mar 15.
See more >>
Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy.
Berenson, J.R., Yeh, H.S.; Clin Lymphoma Myeloma. 2006 Nov.
See more >>